The rapid rise of targeted drugs and biologics in oncology has led to the creation of a variation to the typical trial design that can include multiple expansion cohorts. A multiple expansion cohort trial allows sponsors who spot positive responses to an investigational drug during early stages of testing to expand the trial using additional single-arm studies; these designs can cut the typical development times for conventional trials in half. (Applied Clinical Trials)